Is next-day discharge after uncomplicated transcatheter aortic valve implantation the new standard of care?
作者信息
Costa Giuliano, Sammartino Sofia
出版信息
EuroIntervention. 2024 Dec 16;20(24):e1488-e1489. doi: 10.4244/EIJ-E-24-00056.
Abstract
摘要
相似文献
1
Is next-day discharge after uncomplicated transcatheter aortic valve implantation the new standard of care?简单经导管主动脉瓣植入术后次日出院是新的护理标准吗？
EuroIntervention. 2024 Dec 16;20(24):e1488-e1489. doi: 10.4244/EIJ-E-24-00056.
2
Next-Day Discharge vs Early Discharge After Transcatheter Aortic Valve Replacement: Systematic Review and Meta-Analysis.经导管主动脉瓣置换术后次日出院与早期出院的比较：系统评价和荟萃分析。
Curr Probl Cardiol. 2022 Oct;47(10):100998. doi: 10.1016/j.cpcardiol.2021.100998. Epub 2021 Sep 24.
3
Temporal Trends, Outcomes, and Predictors of Next-Day Discharge and Readmission Following Uncomplicated Evolut Transcatheter Aortic Valve Replacement: A Propensity Score-Matched Analysis.经皮主动脉瓣置换术后无并发症患者次日出院和再入院的时间趋势、结局及预测因素：倾向评分匹配分析。
J Am Heart Assoc. 2024 May 7;13(9):e033846. doi: 10.1161/JAHA.123.033846. Epub 2024 Apr 19.
4
Readmissions after next-day discharge following transcatheter aortic valve implantation.经导管主动脉瓣植入术后次日出院后的再入院情况。
EuroIntervention. 2024 Dec 16;20(24):e1505-e1519. doi: 10.4244/EIJ-D-24-00514.
5
Factors associated with heart failure events in patients with new-onset persistent left bundle branch block at discharge after transcatheter aortic valve replacement.经导管主动脉瓣置换术后出院时新发持续性左束支传导阻滞患者心力衰竭事件的相关因素。
Heart Rhythm. 2025 Jul;22(7):e132-e140. doi: 10.1016/j.hrthm.2025.01.035. Epub 2025 Jan 31.
6
Transcatheter aortic valve implantation for high-risk patients with severe aortic stenosis: A systematic review.经导管主动脉瓣植入术治疗高危重度主动脉瓣狭窄患者：系统评价。
J Thorac Cardiovasc Surg. 2010 Jun;139(6):1519-28. doi: 10.1016/j.jtcvs.2009.08.037. Epub 2009 Oct 28.
7
Transcatheter aortic valve implantation with SAPIEN 3 versus surgical aortic valve replacement in patients with symptomatic severe aortic stenosis at low risk of surgical mortality: a cost-utility analysis for Switzerland.经导管主动脉瓣植入术（SAPIEN 3）与外科主动脉瓣置换术治疗低外科死亡率手术风险的有症状重度主动脉瓣狭窄患者：瑞士的成本-效用分析。
Swiss Med Wkly. 2024 Oct 24;154:3558. doi: 10.57187/s.3558.
8
Transcatheter Aortic Valve Implantation With or Without Percutaneous Coronary Artery Revascularization Strategy: A Systematic Review and Meta-Analysis.经导管主动脉瓣植入术联合或不联合经皮冠状动脉血运重建策略：一项系统评价与荟萃分析
J Am Heart Assoc. 2017 Jun 27;6(6):e005960. doi: 10.1161/JAHA.117.005960.
9
Study protocol for an internahaational prospective non-randomised trial evaluating the long-term outcomes of transcatheter aortic valve implantation versus surgical aortic valve replacement for aortic-valve stenosis in patients at risk to severe valve obstruction: the TAVISAR trial.一项国际前瞻性非随机试验的研究方案，该试验旨在评估经导管主动脉瓣植入术与外科主动脉瓣置换术治疗有严重瓣膜狭窄风险的主动脉瓣狭窄患者的长期疗效：TAVISAR试验
BMJ Open. 2025 May 24;15(5):e101417. doi: 10.1136/bmjopen-2025-101417.
10
Health Related Quality of Life (HRQoL) after transcatheter aortic valve implantation in aortic stenosis patients: exploring a novel threshold for clinically significant improvement after 12 months.主动脉瓣狭窄患者经导管主动脉瓣植入术后的健康相关生活质量（HRQoL）：探索12个月后具有临床显著改善的新阈值。
J Patient Rep Outcomes. 2025 May 26;9(1):58. doi: 10.1186/s41687-025-00894-1.
本文引用的文献
1
Next-Day Discharge After Transcatheter Aortic Valve Implantation With the ACURATE neo/neo2 Self-Expanding Aortic Bioprosthesis.经导管主动脉瓣植入术后次日出院：ACURATE neo/neo2 自膨式主动脉生物瓣。
Am J Cardiol. 2024 Sep 15;227:65-74. doi: 10.1016/j.amjcard.2024.07.005. Epub 2024 Jul 10.
2
Safety and feasibility of early discharge after transcatheter aortic valve implantation with ACURATE Neo-the POLESTAR trial.经导管主动脉瓣植入术联合ACURATE Neo早期出院的安全性和可行性——POLESTAR试验
Clin Res Cardiol. 2025 Mar;114(3):341-349. doi: 10.1007/s00392-024-02436-z. Epub 2024 Apr 15.
3
Clinical Impact of Standardized TAVR Technique and Care Pathway: Insights From the Optimize PRO Study.标准化 TAVR 技术和护理路径的临床影响：来自 Optimize PRO 研究的见解。
JACC Cardiovasc Interv. 2023 Mar 13;16(5):558-570. doi: 10.1016/j.jcin.2023.01.016.
4
Predictors and safety of next-day discharge in patients undergoing transfemoral transcatheter aortic valve implantation.经股动脉经导管主动脉瓣植入术患者次日出院的预测因素和安全性。
EuroIntervention. 2020 Aug 7;16(6):e494-e501. doi: 10.4244/EIJ-D-19-01080.
5
The Vancouver 3M (Multidisciplinary, Multimodality, But Minimalist) Clinical Pathway Facilitates Safe Next-Day Discharge Home at Low-, Medium-, and High-Volume Transfemoral Transcatheter Aortic Valve Replacement Centers: The 3M TAVR Study.温哥华 3M（多学科、多模式但简约）临床路径促进低、中、高容量经股动脉经导管主动脉瓣置换中心安全次日出院：3M TAVR 研究。
JACC Cardiovasc Interv. 2019 Mar 11;12(5):459-469. doi: 10.1016/j.jcin.2018.12.020.
6
Optimising patient discharge management after transfemoral transcatheter aortic valve implantation: the multicentre European FAST-TAVI trial.经股动脉主动脉瓣置换术后患者出院管理的优化：多中心欧洲 FAST-TAVI 试验。
EuroIntervention. 2019 Jun 20;15(2):147-154. doi: 10.4244/EIJ-D-18-01197.
7
Predictors and Clinical Outcomes of Next-Day Discharge After Minimalist Transfemoral Transcatheter Aortic Valve Replacement.微创经股动脉主动脉瓣置换术后次日出院的预测因素和临床转归。
JACC Cardiovasc Interv. 2018 Jan 22;11(2):107-115. doi: 10.1016/j.jcin.2017.10.021.
Zotero 插件